BioMed X - the best of two worlds in one Institute
@biomedx.bsky.social
170 followers 440 following 35 posts
We accelerate the pace of innovation in biomedical research and drug discovery & development by combining the best of both worlds – academia and industry. Our innovation model: https://pubmed.ncbi.nlm.nih.gov/39235485/
Posts Media Videos Starter Packs
Pinned
biomedx.bsky.social
New Call for Application! Reimagining drug delivery 🚀
#BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw
📅 Submit your proposal before #October 12, 2025
biomedx.bsky.social
🚨 New episode of #VoicesOfBioMedX! 🎙️

Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.

Listen to the interview: www.youtube.com/watch?v=ARPz...
Day in the life of a Research Assistant | Elizaveta Savochkina | Voices of BiomedX EP 06
YouTube video by BioMed X Institute
www.youtube.com
biomedx.bsky.social
Join us at @events.embl.org Heidelberg for an inspiring #webinar with Christian Tidona, Founder and Managing Director of BioMed X Institute 🎙

📅 Visit us at EMBL Heidelberg or join 🌐Online via Zoom
🕚 October 10th, 2025 | 11:00 – 12:00 (CEST)
👉 Register here: embl-org.zoom.us/webinar/regi...
biomedx.bsky.social
New Call for Application! Reimagining drug delivery 🚀
#BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw
📅 Submit your proposal before #October 12, 2025
biomedx.bsky.social
🚨 New episode of #VoicesOfBioMedX! 🎙️

Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
biomedx.bsky.social
💡 New Call for Application: BioMed X & #Servier
are launching the first XSeed Labs research project in Paris-Saclay! Focus: #AI-powered design of #bispecific #antibodies for #cancer #therapy. 🧬 Submit your proposal by August 31 2025: career.bmedx.com/call/2025-XP...
Reposted by BioMed X - the best of two worlds in one Institute
imbmainz.bsky.social
A day well spent at the 2nd Life Sciences Postdoc Symposium. Thank you to our speakers Christian Tidona @biomedx.bsky.social, Eckhard Thines @unimainz.bsky.social, Marie-Theres Weil #BioNTech & Verawan Boonsanay-Michel #sanofi for their inspiring contributions. And of course to all our participants!
biomedx.bsky.social
Info Session on “New Platform for Next-Generation Intraocular Biologics" in partnership with #Boehringer #Ingelheim Call! Available positions for this call include: 1 Group Leader, 2 Postdoctoral Researchers, and 2 Research Assistants
us02web.zoom.us/webinar/regi...
biomedx.bsky.social
Are you a U.S.-based academic PI who lost (or may lose) #NIHfunding? 🧠 Apply for #XBridge by @BioMed_X — a new way to continue your research in a fully funded pharma–academia setting in 🇩🇪 Heidelberg or 🇺🇸 New Haven.
🎥 Missed the webinar? Catch the replay now! youtu.be/miqF_wnclOg #biomedicalresearch
Reposted by BioMed X - the best of two worlds in one Institute
cnb-csic.bsky.social
📢 Don't miss tomorrow's seminar: 'Tracing mitochondrial Dysfunction Signatures in Aging and Autoimmunity', by Dr Gorjana Rackov from the BioMed X Institute, Heidelberg (@biomedx.bsky.social), Germany.

🗓️ 30 May
🕛 12:00
📍 CNB Lecture Hall #CNB_CSIC
biomedx.bsky.social
@BioMedXInst & @Boehringer invite researchers to develop next-gen intraocular biologics at #XSeedLabs (CT, USA) to reduce the burden of frequent injections in #retinal disease.
Apply by July 12 👉 career.bmedx.com/call/2025-RD...
#biologics #ophthalmology #pharma
BioMed X Institute
BioMed X Application System
career.bmedx.com
biomedx.bsky.social
We’re launching our first collaboration with Daiichi Sankyo Co., Ltd. on "New Strategies for Targeting Solid Tumors with Multi-Specific Biologics". Boot camp kicks off in Heidelberg—welcome to our partners & participants!
🔗 bmedx.com/news-events/...
biomedx.bsky.social
🎉Congratulations to our #PTA Team on receiving three 𝐄𝐅𝐈𝐒-𝐄𝐉𝐈 𝐘𝐨𝐮𝐧𝐠 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐠𝐚𝐭𝐨𝐫 𝐓𝐫𝐚𝐯𝐞𝐥 𝐀𝐰𝐚𝐫𝐝𝐬 at the 4th #Resolution #Days Meeting in Frankfurt!
biomedx.bsky.social
🌉 Today we launch #XBridge: a unique matchmaking program for U.S. researchers hit by #NIH #funding gaps.
We invite PIs to submit existing NIH proposals to connect with pharma partners via our platform. bio.mx/news/press-r...

Not a grant—an opportunity to keep science moving.
#StandUpForScience 🔬
biomedx.bsky.social
We are excited to announce that @johnmlindner.bsky.social , our Head of Immunology Discovery & Head of Research USA, will be introducing T-FINDER at the 6th TCR-Based Therapies Summit in Boston on Wednesday, April 2, 2025.
#precision #immunotherapy. tcr-therapies-summit.com/day-one/?utm...
biomedx.bsky.social
🔬 Advancing AI in Drug Development: BioMed X Institute at #ICLR2025 integrating #ComputationalBiology, and #KnowledgeGraphs, and #AgenticAI to transform drug development and clinical translation. Congratulations Team VPE!
biomedx.bsky.social
Our Group Leader, Kyungbo Kim, at 2025 China International Biotechnology Conference in Beijing (April 16-18, 2025)!Novel approach transporting complex macromolecules, even micron-sized bacteria across the intestinal epithelium, by harnessing gut immune cells. nbc2025.eventscribe.net/index.asp?pr...
biomedx.bsky.social
🔬 The Diary of a Scientist: A Webinar Series on Careers in Science 🎙️What does it really take to build a career in science? How do you navigate the transition between academia and industry? Register for free: webinar! us02web.zoom.us/webinar/regi...
biomedx.bsky.social
Deadline extended! You have time to submit your proposal until TOMORROW March 11th!
biomedx.bsky.social
🚨 New Call for Application Alert! 🚨
💡 Project Title: New Strategies for Targeting of Solid Tumors with Multi-Specific Biologics (MTT)
🤝In collaboration with Daiichi Sankyo
🌍Location: Heidelberg
🗓️Apply by: March 9, 2025
📍Innovation Boot Camp: May 12-16, 2025
🔗Apply here: career.bio.mx/call/2025-BM...
biomedx.bsky.social
🚀 𝗡𝗘𝗪 𝗖𝗮𝗹𝗹: 𝗦𝘁𝗮𝗿𝘁 𝗬𝗼𝘂𝗿 𝗢𝘄𝗻 𝗔𝗜-𝗣𝗼𝘄𝗲𝗿𝗲𝗱 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗶𝗻 𝗜𝘀𝗿𝗮𝗲𝗹!🔹 We are looking for:
🧑‍🔬 𝟭 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝟮 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗖𝗼-𝗙𝗼𝘂𝗻𝗱𝗲𝗿𝘀 – Experts in computational biology, ML, bioinformatics, language models, encryption, and complex disease biology. career.bio.mx/call/2025-AI...
Reposted by BioMed X - the best of two worlds in one Institute
vonderleyen.ec.europa.eu
Signed!

Two Global Gateway projects with huge potential for Barbados.

One agreement with @biomedx.bsky.social for pharmaceutical innovation.

And the first green hydrogen storage facility of the Caribbean with HDF Energy.
biomedx.bsky.social
Virtual patients and biomedical knowledge graphs—two groundbreaking technologies, yet often developed in isolation. Now, it's time to change that. Join our next #Hackathon and be part of the future.
docs.google.com/forms/d/e/1F...
biomedx.bsky.social
🚀 Advancing High-Dimensional Flow Cytometry at BioMed X! Advanced Spectral Flow Cytometry Workshop, mastering the design, execution, and analysis of high-dimensional flow experiments using the Sony ID7000. #FlowCytometry
biomedx.bsky.social
#cancerday
biomedx.bsky.social
𝐖𝐡𝐚𝐭 𝐢𝐟 𝐮𝐧𝐥𝐨𝐜𝐤𝐢𝐧𝐠 𝐭𝐡𝐞 𝐬𝐞𝐜𝐫𝐞𝐭𝐬 𝐨𝐟 𝐧𝐞𝐮𝐭𝐫𝐨𝐩𝐡𝐢𝐥 𝐛𝐞𝐡𝐚𝐯𝐢𝐨𝐫 𝐜𝐨𝐮𝐥𝐝 𝐫𝐞𝐝𝐞𝐟𝐢𝐧𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭? Immunity review on neutrophil plasticity in cancer and emerging strategies to reprogram them from tumor accomplices to fighters. pubmed.ncbi.nlm.nih.gov/39813993/one
How we address this: bio.mx/research-tea...
Adaptations of neutrophils in cancer - PubMed
There is a renewed interest in neutrophil biology, largely instigated by their prominence in cancer. From an immunologist's perspective, a conceptual breakthrough is the realization that prototypical ...
pubmed.ncbi.nlm.nih.gov
biomedx.bsky.social
𝐖𝐡𝐚𝐭 𝐢𝐟 𝐮𝐧𝐥𝐨𝐜𝐤𝐢𝐧𝐠 𝐭𝐡𝐞 𝐬𝐞𝐜𝐫𝐞𝐭𝐬 𝐨𝐟 𝐧𝐞𝐮𝐭𝐫𝐨𝐩𝐡𝐢𝐥 𝐛𝐞𝐡𝐚𝐯𝐢𝐨𝐫 𝐜𝐨𝐮𝐥𝐝 𝐫𝐞𝐝𝐞𝐟𝐢𝐧𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭? Immunity review on neutrophil plasticity in cancer and emerging strategies to reprogram them from tumor accomplices to fighters. pubmed.ncbi.nlm.nih.gov/39813993/one
How we address this: bio.mx/research-tea...
Adaptations of neutrophils in cancer - PubMed
There is a renewed interest in neutrophil biology, largely instigated by their prominence in cancer. From an immunologist's perspective, a conceptual breakthrough is the realization that prototypical ...
pubmed.ncbi.nlm.nih.gov